Drug
Etalanetug clinical trials
Also written E2814.
- studies test it
- 5
- open now
- 0
- in phase 3
- 2
- first study started
- 2012
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
5 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 4
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 2
Eisai Inc. (3) · Washington University School of Medicine (2)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses etalanetug is read from its arms, and is right about nine times in ten.
Testing it · 5
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)Active, not recruitingPhase 2/3Washington University School of MedicineNCT05269394Written as E2814
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001Active, not recruitingPhase 2/3Washington University School of MedicineNCT01760005Written as E2814
- A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's DiseaseActive, not recruitingPhase 2Eisai Inc.NCT06602258Written as E2814
- A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's DiseaseCompletedPhase 1/2Eisai Inc.NCT04971733Written as E2814
- A Study to Assess Safety, Tolerability, Pharmacokinetics (PK), Immunogenicity, and Pharmacodynamics (PD) of Intravenous Infusions of E2814 in Healthy ParticipantsCompletedPhase 1Eisai Inc.NCT04231513Written as E2814
Codes
What other systems call etalanetug · ClinicalTrials.gg INT018015
- UNII (FDA) TE9GZ84LVNETALANETUGOne source FDA
- NCI Thesaurus C206912EtalanetugOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | TE9GZ84LVN | ETALANETUG | One source FDA |
| NCI Thesaurus | C206912 | Etalanetug | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.